Bank of New York Mellon’s Rain Oncology Inc. Common Stock RAIN Stock Holding History

Bank of New York Mellon’s Portfolio RAIN Stock Details RAIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-41,801	Closed	-$50.2K	–	4382
2023 Q4	$50.2K	Hold	41,801	–	–	﹤0.01%	4158
2023 Q3	$36K	Hold	41,801	–	–	﹤0.01%	4196
2023 Q2	$50.2K	Buy	+41,801	New	+$209K	﹤0.01%	4180
2022 Q2	–	Sell	-36,728	Closed	-$186K	–	4731
2022 Q1	$186K	Buy	36,728 +2,276	+7%	+$18.2K	﹤0.01%	4272
2021 Q4	$443K	Buy	34,452 +13,997	+68%	+$200K	﹤0.01%	3880
2021 Q3	$306K	Buy	20,455 +7,008	+52%	+$120K	﹤0.01%	4032
2021 Q2	$209K	Buy	+13,447	New	+$236K	﹤0.01%	4090

Bank of New York Mellon's RAIN Position: Q1 2024 in Review

Bank of New York Mellon sold out of Rain Oncology Inc. Common Stock (RAIN) in Q1 2024, closing a stake of 41,801 shares — an estimated $50.2K sold.

Bank of New York Mellon first reported a position in RAIN in Q2 2021 and held it in 7 quarters. The position peaked at $443K in Q4 2021. 0 funds tracked by Wall St. Rank hold RAIN as of Q1 2024.

Bank of New York Mellon reported no remaining Rain Oncology Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Bank of New York Mellon sold 41,801 Rain Oncology Inc. Common Stock shares in Q1 2024, an estimated $50.2K.
Bank of New York Mellon first reported a position in Rain Oncology Inc. Common Stock in Q2 2021 and held it in 7 quarters.
Bank of New York Mellon's Rain Oncology Inc. Common Stock position peaked at $443K in Q4 2021.
0 funds tracked by Wall St. Rank held Rain Oncology Inc. Common Stock as of Q1 2024.

Based on Bank of New York Mellon's 13F filing for Q1 2024, filed 25 Apr 2024.